Daisuke Aoki

16.9k total citations · 5 hit papers
440 papers, 11.0k citations indexed

About

Daisuke Aoki is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Daisuke Aoki has authored 440 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Reproductive Medicine, 135 papers in Obstetrics and Gynecology and 128 papers in Molecular Biology. Recurrent topics in Daisuke Aoki's work include Ovarian cancer diagnosis and treatment (130 papers), Endometrial and Cervical Cancer Treatments (121 papers) and Cervical Cancer and HPV Research (54 papers). Daisuke Aoki is often cited by papers focused on Ovarian cancer diagnosis and treatment (130 papers), Endometrial and Cervical Cancer Treatments (121 papers) and Cervical Cancer and HPV Research (54 papers). Daisuke Aoki collaborates with scholars based in Japan, United States and United Kingdom. Daisuke Aoki's co-authors include Kouji Banno, Neerja Bhatla, Rengaswamy Sankaranarayanan, Daya Nand Sharma, Nobuyuki Susumu, Akira Hirasawa, Wataru Yamagami, Megumi Yanokura, Iori Kisu and Eiichiro Tominaga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Daisuke Aoki

432 papers receiving 10.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer of the cervix uteri

2018 752 citations Daisuke Aoki et al. International Journal of Gynecology & Obstetrics profile →
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

2009 502 citations Fumiaki Takahashi, Daisuke Aoki et al. profile →
Endometrial cancer

2021 340 citations Daisuke Aoki et al. profile →
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

2013 331 citations Fumiaki Takahashi, Daisuke Aoki et al. profile →
Cancer of the cervix uteri: 2021 update

2021 282 citations Daisuke Aoki et al. International Journal of Gynecology & Obstetrics profile →

Peers

Countries citing papers authored by Daisuke Aoki

Since Specialization

Citations

This map shows the geographic impact of Daisuke Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Aoki more than expected).

Fields of papers citing papers by Daisuke Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Aoki. The network helps show where Daisuke Aoki may publish in the future.

Co-authorship network of co-authors of Daisuke Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Aoki. A scholar is included among the top collaborators of Daisuke Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Aoki. Daisuke Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan 2024 ·Journal of Gynecologic Oncology ·Hiroko Machida, Koji Matsuo, Takahiro Higashi, Daisuke Aoki, Takayuki Enomoto, Aikou Okamoto, Hidetaka Katabuchi, Satoru Nagase, Masaki Mandai, Nobuo Yaegashi, Wataru Yamagami, Mikio Mikami	0
2	Reduced expression of gangliosides with GM2-determinant in cervical carcinoma-derived cells after subcutaneous transplantation into nude mice 2023 ·Human Cell ·Kyoko Tanaka, Isao Murakami, Mikio Mikami, Daisuke Aoki, Masao Iwamori	1
3	Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer 2023 ·International Journal of Clinical Oncology ·(unknown), Tatsuyuki Chiyoda, Kohei Nakamura, Kensuke Sakai, (unknown), Hiroshi Nishio, Yusuke Kobayashi, Takashi Iwata, Kouji Banno, Wataru Yamagami, Hiroshi Nishihara, Daisuke Aoki	1
4	Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer 2022 ·International Journal of Clinical Oncology ·(unknown), (unknown), Tatsuyuki Chiyoda, Mio Takahashi, (unknown), (unknown), (unknown), Kensuke Sakai, Yusuke Kobayashi, Wataru Yamagami, Daisuke Aoki	5
5	Evaluation of the role of intraoperative frozen section and magnetic resonance imaging in endometrial cancer 2022 ·International Journal of Gynecology & Obstetrics ·(unknown), (unknown), Wataru Yamagami, Miho Kawaida, (unknown), (unknown), Kensuke Sakai, Takeshi Makabe, Tatsuyuki Chiyoda, Yusuke Kobayashi, Fumio Kataoka, Daisuke Aoki	2
6	Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO) 2022 ·Journal of Gynecologic Oncology ·Yusuke Kobayashi, Kenta Masuda, (unknown), Kazuhiro Takehara, Hitoshi Tsuda, Yoh Watanabe, Katsutoshi Oda, Satoru Nagase, Masaki Mandai, Aikou Okamoto, Nobuo Yaegashi, Mikio Mikami, Takayuki Enomoto, Daisuke Aoki, Hidetaka Katabuchi	3
7	The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate 2021 ·Journal of Gynecologic Oncology ·(unknown), Tohru Morisada, Kumiko Saika, (unknown), Etsuko Miyagi, Kiyoshi Ito, Hirokazu Takahashi, Tomio Nakayama, Hiroshi Saito, Daisuke Aoki	5
8	Atypical vessels in hysteroscopy: Usefulness in prediction of malignant diseases in patients treated with tamoxifen 2021 ·Journal of obstetrics and gynaecology research ·(unknown), Kensuke Sakai, Wataru Yamagami, (unknown), Takeshi Makabe, (unknown), Tatsuyuki Chiyoda, Fumio Kataoka, Kouji Banno, Daisuke Aoki	1
9	The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee 2021 ·Journal of Gynecologic Oncology ·Masae Ikeda, Masako Shida, Shogo Shigeta, Satoru Nagase, Fumiaki Takahashi, Wataru Yamagami, Hidetaka Katabuchi, Nobuo Yaegashi, Daisuke Aoki, Mikio Mikami	8
10	A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapy 2021 ·International Journal of Gynecology & Obstetrics ·Kensuke Sakai, Wataru Yamagami, Hiroko Machida, Yasuhiko Ebina, Yoichi Kobayashi, Tsutomu Tabata, Masanori Kaneuchi, Satoru Nagase, Takayuki Enomoto, Daisuke Aoki, Mikio Mikami	2
11	Current status of cancer immunotherapy for gynecologic malignancies 2020 ·Japanese Journal of Clinical Oncology ·Hiroshi Nishio, Takashi Iwata, Daisuke Aoki	18
12	Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE‐100 2020 ·Cancer Science ·Shin Nishio, Koji Matsumoto, Kazuhiro Takehara, Naoki Kawamura, Kosei Hasegawa, Nobuhiro Takeshima, Daisuke Aoki, Shoji Kamiura, Atsushi Arakawa, Eiji Kondo, Tomoko Hirakawa, Keiko Yamamoto, Masayuki Aoki, Karen Stein, Stephen J. O’Keefe, Keiichi Fujiwara, Kimio Ushijima	31
13	A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients 2019 ·Journal of obstetrics and gynaecology research ·(unknown), Miyuki Harada, Chisato Kunitomi, (unknown), Gentaro Izumi, Tetsuya Hirata, Tomoyuki Fujii, Nao Suzuki, Ken‐ichirou Morishige, Daisuke Aoki, Minoru Irahara, Koichiro Tsugawa, Mitsune Tanimoto, Hiroyuki Nishiyama, Hajime Hosoi, Kazuhiko Sugiyama, Akira Kawai, Yutaka Osuga	16
14	Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma 2019 ·Journal of Gynecologic Oncology ·Moito Iijima, Noriyuki Okonogi, Nakako Izumi Nakajima, (unknown), Hiroaki Kanda, (unknown), Yusuke Kobayashi, Kouji Banno, Masaru Wakatsuki, Shigeru Yamada, Tadashi Kamada, Daisuke Aoki, Sumitaka Hasegawa	28
15	LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer 2019 ·Journal of Gynecologic Oncology ·Haruko Kunitomi, Yusuke Kobayashi, Ren‐Chin Wu, Takashi Takeda, Eiichiro Tominaga, Kouji Banno, Daisuke Aoki	40
16	Current state and outlook for drug repositioning anticipated in the field of ovarian cancer 2018 ·Journal of Gynecologic Oncology ·Yusuke Kobayashi, Kouji Banno, Haruko Kunitomi, Eiichiro Tominaga, Daisuke Aoki	30
17	miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer 2011 ·Cancer Research ·Tomohiko Tsuruta, Ken‐ichi Kozaki, Atsushi Uesugi, Mayuko Furuta, Akira Hirasawa, Issei Imoto, Nobuyuki Susumu, Daisuke Aoki, Johji Inazawa	185
18	Gynecological tumors in patients with Peutz-Jeghers syndrome (PJS) 2011 ·Arisa Ueki, Iori Kisu, Kouji Banno, Megumi Yanokura, (unknown), Yusuke Kobayashi, Akira Hirasawa, Daisuke Aoki	8
19	Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma 2009 ·Clinical Cancer Research ·Daisuke Aoki, Yoshinao Oda, Satoshi Hattori, Kenichi Taguchi, Yoshihiro Ohishi, Yuji Basaki, Shinji Oie, Nao Suzuki, Suminori Kono, Masazumi Tsuneyoshi, Mayumi Ono, Takashi Yanagawa, Michihiko Kuwano	55
20	Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation 2007 ·Proceedings of the National Academy of Sciences ·Kazuhiro Sugihara, Daijiro Sugiyama, James Byrne, Don P. Wolf, (unknown), Yoichi Kobayashi, Maryam Kabir‐Salmani, Daita Nadano, Daisuke Aoki, Shiro Nozawa, Jun Nakayama, Tomas Mustelin, Erkki Ruoslahti, Naoto Yamaguchi, Michiko N. Fukuda	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact